"India continues to be placed on the Priority Watch List under the US Special 301 on account of USA's assessment of Indian IPR protection being inadequate," Commerce and Industry Minister Nirmala Sitharaman said, in a written reply to the Lok Sabha.
She said the report issued by the US is a "unilateral measure to create pressure on countries to enhance IPR protection beyond the TRIPS (Trade-related aspects of intellectual property rights) agreement".
"Special 301, which is an extra territorial application of the domestic law of a country, is inconsistent with the established norms of the WTO," she added.
Countries in this list, according to the US, are not able to protect and properly enforce intellectual property rights.
The US government has always raised concerns on India's IPR policy, saying it discriminates American companies. However, India has maintained that its patent policy is in compliance with global obligations.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
